|
Delayed
London S.E.
04:34:18 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 5.800 GBX | +0.87% |
|
+8.41% | -63.17% |
| 10-15 | SkinBioTherapeutics plc Announces Change of Registered Office Address | CI |
| 09-22 | EARNINGS and TRADING: Aeorema ups guidance; ZCCM swings to profit | AN |
| Market Cap | 14.9M 19.75M 17.63M 16.38M 28.04M 1.87B 28.54M 197M 77M 976M 74.11M 72.54M 3.12B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 18.44M 24.44M 21.81M 20.27M 34.69M 2.31B 35.32M 244M 95.28M 1.21B 91.7M 89.76M 3.86B | EV / Sales 2026 * |
2.97x | EV / Sales 2027 * | 2.25x |
| Free-Float |
58.86% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SBTX | Delayed | |
Deutsche Boerse AG
| 5KW | Delayed | |
|
Börse Stuttgart
| 5KW | Delayed |
Last Transcript: SkinBioTherapeutics plc
| 1 day | +0.87% | ||
| 1 week | +8.41% | ||
| Current month | -3.33% | ||
| 1 month | -37.30% | ||
| 3 months | -40.51% | ||
| 6 months | -40.21% | ||
| Current year | -63.17% |
| 1 week | 5.25 |  | 6.5 |
| 1 month | 5 | | 9.05 |
| Current year | 5 | | 23 |
| 1 year | 5 | | 23 |
| 3 years | 5 | | 29.5 |
| 5 years | 5 | | 78.25 |
| 10 years | 5 | | 88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rachel Parsonage
CEO | Chief Executive Officer | - | 2026-03-01 |
Anita Slater
DFI | Director of Finance/CFO | - | 2026-08-23 |
| Comptroller/Controller/Auditor | - | 2023-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2017-02-28 | |
Alyson Levett
CHM | Chairman | 60 | - |
Rachel Parsonage
BRD | Director/Board Member | - | 2026-03-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/14/23 | Buy | Chief Executive Officer | 122,517 | 0.0708% | ||
| 4/14/23 | Sell | Chief Executive Officer | 123,878 | 0.0715% | ||
| 3/9/23 | Buy | Chief Financial Officer | 86,387 | 0.0499% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +8.41% | -58.87% | -73.02% | 19.75M | |
| +0.21% | -4.63% | +55.34% | +71.32% | 68.98B | |
| -0.82% | +3.24% | +5.74% | +60.00% | 53.15B | |
| -0.76% | +4.79% | +9.38% | +40.72% | 50.83B | |
| +3.45% | +4.70% | +33.44% | +35.96% | 44.61B | |
| -2.20% | +0.61% | +281.88% | +532.76% | 40.57B | |
| +6.43% | +6.84% | +18.32% | +109.23% | 42.53B | |
| +1.28% | +1.39% | +11.69% | +45.10% | 30.95B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.44B | |
| +1.74% | -2.02% | -13.55% | -12.92% | 22.66B | |
| Average | +0.80% | +2.17% | +37.48% | +80.75% | 37.97B | |
| Weighted average by Cap. | +0.78% | +2.33% | +50.45% | +102.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.2M 8.22M 7.33M 6.82M 11.66M 778M 11.87M 81.88M 32.03M 406M 30.83M 30.18M 1.3B | 8.2M 10.87M 9.7M 9.02M 15.43M 1.03B 15.71M 108M 42.37M 537M 40.78M 39.92M 1.72B |
| Net income | - | - |
| Net Debt | 3.54M 4.69M 4.18M 3.89M 6.66M 444M 6.78M 46.72M 18.28M 232M 17.59M 17.22M 741M | 3.57M 4.73M 4.22M 3.93M 6.72M 448M 6.84M 47.15M 18.45M 234M 17.76M 17.38M 748M |
Employees
41
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | GBX 5.800 | +0.87% | 14,659 |
| 26-10-15 | GBX 5.750 | 0.00% | 962,606 |
| 26-10-14 | GBX 5.750 | -4.17% | 226,699 |
| 26-10-13 | GBX 6.000 | +11.11% | 1,005,378 |
| 26-10-12 | GBX 5.400 | +0.93% | 314,331 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0575GBP
Average target price
0.2900GBP
Spread / Average Target
+404.35%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBTX Stock
Select your edition
All financial news and data tailored to specific country editions
